Aug 05, 2016 - Mylan (MYL), which is set to report second-quarter 2016 results on Aug 9, delivered a positive earnings surprise of 1.33% last quarter.
Aug 05, 2016 - TransDigm Group Incorporated (TDG) is set to report third-quarter fiscal 2016 results, after the closing bell on Aug 9.
Aug 05, 2016 - Last quarter, BioDelivery's loss was in-line with expectations. Let's see how things are shaping up for the second quarter of 2016.
Aug 05, 2016 - Our proven model does not conclusively show that Jazz (JAZZ) is likely to beat earnings estimates this quarter.
Aug 04, 2016 - With no approved product in its portfolio, investors will remain focused on pipeline related updates from Celldex (CLDX).
Aug 04, 2016 - Allergan's (AGN) Earnings ESP, which represents the difference between the Most Accurate estimate and the Zacks Consensus Estimate, is a negative 1.49% - will the stock disappoint?
Aug 04, 2016 - With Repros being a development-stage company, investors will remain focused on the company's pipeline and cash burn.
Aug 04, 2016 - With Kite (KITE) being a development stage company, investor focus will remain on the company's pipeline updates and cash burn.
Jul 29, 2016 - ARIAD (ARIA) swung to earnings in the second quarter while Iclusig sales continued to grow.
Jul 26, 2016 - Focus will remain on the performance of ARIAD's (ARIA) leukemia drug, Iclusig.